IGLL5 expression in MM cell lines within the CCLE is second only to Burkitt’s Lymphoma cell lines; more generally, and as with DERL3, IGLL5 expression is higher in B-cell malignancies than in other cancer types. This evidence concerns the gene IGLL5 and Miyoshi myopathy.